Compass Therapeutics (CMPX) Short term Debt (2019 - 2021)
Compass Therapeutics (CMPX) posted Short term Debt of $3.7 million for Q3 2021, down 49.91% sequentially from $7.5 million in Q1 2021, and down 49.82% YoY from $7.5 million in Q3 2020.
Compass Therapeutics (CMPX) Short term Debt (2019 - 2021) Analysis & Trends
Compass Therapeutics has reported Short term Debt for 3 years, with the latest figure at $3.7 million in Q3 2021.
- Quarterly Short term Debt fell 49.82% year-over-year to $3.7 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $3.7 million (down 49.82% YoY) and the FY2020 annual result came in at $7.5 million, up 33.91% from the prior year.
- Short term Debt eased to $3.7 million in Q3 2021 per CMPX's latest filing, from $7.5 million in the prior quarter.
- Over five years, Short term Debt peaked at $7.5 million in Q1 2021 and troughed at $3.7 million in Q3 2021.
- A 3-year average of $6.5 million and a median of $7.5 million in 2020 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2020 and 2021: Short term Debt soared 33.91% in 2020, then sank 49.82% in 2021.
- Over 3 years, Short term Debt stood at $5.6 million in 2019, then jumped by 33.91% to $7.5 million in 2020, then slumped by 49.86% to $3.7 million in 2021.
- According to Business Quant data, Short term Debt over the past three periods registered $3.7 million, $7.5 million, and $7.5 million for Q3 2021, Q1 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 3.74 Mn |
| Mar 31, 2021 | 7.47 Mn |
| Dec 31, 2020 | 7.47 Mn |
| Sep 30, 2020 | 7.46 Mn |
| Jun 30, 2020 | 7.45 Mn |
| Dec 31, 2019 | 5.58 Mn |